Rchr
J-GLOBAL ID:201401095741568593   Update date: Jun. 09, 2020

Asaka Isao

Asaka Isao
Affiliation and department:
Papers (32):
  • Korogi Y, Gotoh S, Ikeo S, Yamamoto Y, Sone N, Tamai K, Konishi S, Nagasaki T, Matsumoto H, Ito I, Chen-Yoshikawa TF, Date H, Hagiwara M, Asaka I, Hotta A, Mishima M, Hirai T. In Vitro Disease Modeling of Hermansky-Pudlak Syndrome Type 2 Using Human Induced Pluripotent Stem Cell-Derived Alveolar Organoids. Stem Cell Reports. 2019. 12. 3. 431-440
  • Nakamura K, Kanda Y, Yamazaki D, Kataoka K, Aoi T, Nakagawa M, Fujii M, Akutsu H, Suemori H, Asaka I, Nakamura Y, Kojima H, Ito Y, Sekino Y, Furue K M. Proposal for “Fundamental principles for microscopic observation of cultured cells”. Tiss. Cult. Res. Commun. 2018. 37. 2. 123-131
  • Fumiko Honda-Ozaki, Madoka Terashima, Akira Niwa, Norikazu Saiki, Yuri Kawasaki, Haruna Ito, Akitsu Hotta, Ayako Nagahashi, Koichi Igura, Isao Asaka, Hongmei Lisa Li, Masakatsu Yanagimachi, Fukumi Furukawa, Nobuo Kanazawa, Tatsutoshi Nakahata, Megumu K Saito. Pluripotent Stem Cell Model of Nakajo-Nishimura Syndrome Untangles Proinflammatory Pathways Mediated by Oxidative Stress. Stem cell reports. 2018. 10. 6. 1835-1850
  • Hosokawa Y, Toyoda T, Fukui K, Baden MY, Funato M, Kondo Y, Sudo T, Iwahashi H, Kishida M, Okada C, Watanabe A, Asaka I, Osafune K, Imagawa A, Shimomura I. Insulin-producing cells derived from 'induced pluripotent stem cells' of patients with fulminant type 1 diabetes: vulnerability to cytokine insults and increased expression of apoptosis-related genes. J Diabetes Investig. 2018. 9. 3. 481-493
  • Hata M, Ikeda HO, Iwai S, Iida Y, Gotoh N, Asaka I, Ikeda K, Isobe Y, Hori A, Nakagawa S, Yamato S, Arita M, Yoshimura N, Tsujikawa A. Reduction of lipid accumulation rescues Bietti's crystalline dystrophy phenotypes. Proc Natl Acad Sci U S A. 2018. 115. 15. 3936-3941
more...
MISC (1):
  • Hayashi Y, Hsiao E, Sami S, Lancero M, Schlieve C, Yano K, Nagahashi A, Ikeya M, Matsumoto Y, Asaka I, JToguchida J, Conckin B, Yamanaka S. BMP-SMAD-ID axis promotes reprogramming to pluripotency. 第10 回ISSCR(2012.6.14.横浜). 2012
Books (3):
  • Integration-Free Method for the Generation of Human Induced Pluripotent Stem Cells
    Eds: Peterson S, Loring J F, "Human Stem Cell Manual: Second Edition" pp. 165-173, Elsevier. 2012
  • Methods for Evaluating Human Induced Pluripotent Stem Cells
    Eds: Peterson S, Loring J F, "Human Stem Cell Manual: Second Edition" pp. 175-184, Elsevier. 2012
  • Human Induced Pluripotent Stem Cell Generation: Conventional Method
    Eds: Peterson S, Loring J F, "Human Stem Cell Manual: Second Edition" pp. 143-163, Elsevier. 2012
Lectures and oral presentations  (17):
  • The Convenient Establishing Method of Disease Specific iPS Cells from Peripheral Blood Cells
    (The 31st Annual Meeting of the Japanese Society for Alternatives to Animal Experiments 2018)
  • Recapitulating Alveolar Epithelial Type 2 Cell Dysfunction in Hermansky-Pudlak Syndrome Type 2 Patient-derived Induced Pluripotent Stem Cells
    (The 54th Scientific Meeting of the Japanese Medical Society for Lung Surfactant and Biological Interface 2018)
  • A COMPREHENSIVE DISEASE-SPECIFIC IPSC LIBRARY IN JAPAN
    (International Society for Stem Cell Research 2017 Annual Meeting 2017)
  • IN VITRO DISEASE MODELING OF ALVEOLAR PHENOTYPE CAUSED BY AP3B1 DEFICIENCY USING HUMAN INDUCED PLURIPOTENT STEM CELLS
    (International Society for Stem Cell Research 2017 Annual Meeting 2017)
  • IDENTIFICATION OF A NOVEL RISK FACTOR FOR INTRACRANIAL ANEURYSMS IN ADPKD USING IPSC MODELS
    (International Society for Stem Cell Research 2016 Annual Meeting 2016)
more...
Association Membership(s) (3):
THE PHARMACEUTICAL SOCIETY OF JAPAN ,  THE JAPANESE SOCIETY FOR REGENERATIVE MEDICINE ,  THE JAPANESE TISSUE CULTURE ASSOCIATION
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page